DocDollars

Acadia Pharmaceuticals Inc

CA · United States · Reporting entity ID 100000141529

Total reported 2019–2025
$87.7M
#108 of 2,960 reporting companies — 0.1% of all reported industry payments
$21.0M in general payments across 146,706 records, plus $66.7M in research funding across 10,608 records.

How it breaks down

General payments $20,976,901
Research funding $66,688,490

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Acadia Pharmaceuticals Inc reported $87.7M to US doctors and teaching hospitals from 2019 to 2025, ranking #108 of 2,960 reporting companies. 76% of that was research funding and 24% general payments such as consulting, speaking, food and travel. 146,706 general payment records and 10,608 research records were filed.

Common questions about Acadia Pharmaceuticals Inc

How much has Acadia Pharmaceuticals Inc paid US doctors?

Acadia Pharmaceuticals Inc reported $87,665,391 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $20,976,901 in general payments, $66,688,490 in research funding.

How does Acadia Pharmaceuticals Inc rank among drug and device companies?

It ranks #108 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Acadia Pharmaceuticals Inc mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.